Six subjects with normal renal function (NRF) and 6 patients with minimal renal function (MRF) on 3 times weekly
hemodialysis received 150 muCi3H-digoxin-12 alpha orally. Serial urine collections were made for five days or more.
Digoxin and metabolites were separated using diethylaminoethyl
Sephadex LH-20 column chromatography. Mean cumulative percentages of the ingested radioactivity excreted over five days in NRF and MRF groups were: digoin, 54.5% and 14.7%; bis-digitoxoside of
digoxigenin, 2.0% and 0.59%; mono-digitoxoside, 0.8% and 0.19%;
digoxigenin, 0.25% and 0.03%; and
dihydrodigoxin, 0.3% and 0.03%. Half-lives based on the mean rates of disappearance from urine comparing NRF and MRF groups were: for
digoxin 40 hr and 120 hr; for bis-digitoxoside, 11.5 hr and 46 hr; for mono-digitoxoside, 8.5 hr and 12 hr; for
digoxigenin, 2 hr and 7.5 hr; and for
dihydrodigoxin, 1.2 hr and 7.0 hr. Considering the relationships of the five-day cumulative excretion and half-lives of
digoxin and metabolites in the NRF and MRF groups, it appears unlikely that there is a major alteration in the biotransformation of
digoxin in advanced
renal failure when there appears to be a shift from renal to slower biliary excretion.